Niarmedik Farma

Nearmedic Pharma is a prominent Russian pharmaceutical and diagnostic company that specializes in the development, manufacturing, and commercialization of original drug products and medical test systems. The company is most recognized for its flagship antiviral medication, Kagocel, which is a leading treatment for influenza and acute respiratory viral infections in the Russian market. Nearmedic operates a sophisticated, GMP-compliant manufacturing facility in Obninsk, capable of producing both active pharmaceutical ingredients and finished dosage forms. In addition to its pharmaceutical portfolio, the company is a major provider of laboratory diagnostic services and kits for a wide range of infectious diseases. Following a financial restructuring in 2021, the company came under the control of Sberbank, ensuring continued operations of its critical healthcare infrastructure.